Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 3

Conditions

Breast Neoplasms 13126Triple Negative Breast Neoplasms 1148Neoplasms 749Ovarian Neoplasms 680Neoplasm Metastasis 590Lung Neoplasms 582Colorectal Neoplasms 579Prostatic Neoplasms 559Carcinoma, Non-Small-Cell Lung 534Pancreatic Neoplasms 380Melanoma 366Stomach Neoplasms 350Colonic Neoplasms 330Motor Activity 285Breast Neoplasms, Male 285Carcinoma, Intraductal, Noninfiltrating 277Uterine Cervical Neoplasms 266Head and Neck Neoplasms 266Endometrial Neoplasms 256Carcinoma, Renal Cell 216Sarcoma 203Urinary Bladder Neoplasms 192Squamous Cell Carcinoma of Head and Neck 191Lymphedema 190Esophageal Neoplasms 189Breast Carcinoma In Situ 189Brain Neoplasms 183Fatigue 166Carcinoma, Ovarian Epithelial 151Breast Cancer Female 148

Interventions

ribociclib 1Tretinoin 1Letrozole 1Goserelin 1Drug Therapy 1Chemotherapy, Adjuvant 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
HER2 Negative Breast Cancer × Breast × Clear all
NCT06953882 2026-05-26

SELECT

Yale University

Phase 2 Recruiting
140 enrolled
Breast

HER2 Negative Breast Cancer

NCT06731140 2025-11-17

Resilire

Fudan University

Phase 2 Recruiting
10 enrolled
Breast

HER2 Negative Breast Cancer

NCT03568448 2025-05-22

Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging

New Mexico Cancer Research Alliance

Active not recruiting
30 enrolled
Breast

HER2 Negative Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡